Skip to main content
Top

Breast Cancer

Issue 4/2013

Content (15 Articles)

Special Feature

The current status and future perspectives of CSPOR-BC

Tomohiko Aihara, Hirofumi Mukai

Open Access Special Feature

An overview of the Japan Breast Cancer Research Group (JBCRG) activities

Shinji Ohno, Katsumasa Kuroi, Masakazu Toi

Original Article

Harms of screening mammography for breast cancer in Japanese women

Yoshio Kasahara, Masaaki Kawai, Ichiro Tsuji, Eriko Tohno, Takao Yokoe, Minoru Irahara, Akira Tangoku, Noriaki Ohuchi

Original Article

Is MRI useful for the prediction of nipple involvement?

Naomi Sakamoto, Mitsuhiro Tozaki, Kazuei Hoshi, Eisuke Fukuma

Original Article

Clinical importance of androgen receptor in breast cancer patients treated with adjuvant tamoxifen monotherapy

Naoko Honma, Rie Horii, Takuji Iwase, Shigehira Saji, Mamoun Younes, Yoshinori Ito, Futoshi Akiyama

Original Article

Pathological assessment of microinvasive carcinoma of the breast

Miki Mori, Koichiro Tsugawa, Hideko Yamauchi, Hiroshi Yagata, Koyu Suzuki, Sachiko Ohde, Kumiko Soejima, Seigo Nakamura

Original Article

Importance of confirming HER2 overexpression of recurrence lesion in breast cancer patients

Rikiya Nakamura, Naohito Yamamoto, Yasuhide Onai, Yoshihiro Watanabe, Hidetada Kawana, Masaru Miyazaki

Original Article

A clinically relevant bi-cellular murine mammary tumor model as a useful tool for evaluating the effect of retinoic acid signaling on tumor progression

Laura Beatriz Todaro, María José Veloso, Paola Bernadette Campodónico, Lydia Inés Puricelli, Eduardo Francisco Farías, Elisa Dora Bal de Kier Joffé

Original Article

A phase 2 study of sequential neoadjuvant chemotherapy with gemcitabine and doxorubicin followed by gemcitabine and cisplatin in patients with large or locally advanced operable breast cancer: results from long-term follow-up

Pramod K. Julka, Raju T. Chacko, Shona Nag, Rajinder Parshad, Aravindan Nair, Chaitanyanand B. Koppiker, Fen Chao Richard Xue, Helen Barraclough, Navreet Dhindsa, Anil Seth, Anurita Majumdar, Tarun Puri

Case Report

Hepatitis B virus reactivation in adjuvant chemotherapy for breast cancer

Yoshimi Ide, Yoshinori Ito, Shunji Takahashi, Nahomi Tokudome, Kokoro Kobayashi, Tsutomu Sugihara, Masaya Hattori, Masahiro Yokoyama, Akira Uchiyama, Kazuaki Inoue, Norio Sakurai, Kiyohiko Hatake

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine